Answers are grounded in this paper and cite their sources.
A rodent model demonstrates fibrinogenesis driven by hypercoagulability and proinflammatory activation in Chagas disease, suggesting new therapeutic targets.
AT, IT, and CT: Acute, intermediate, and chronic stages of T. cruzi infection, respectively; APTT: Activated partial thromboplastin time; BCV: Bicistronic immunogen; BCVR: BCV adjuvanted with RIG-I agonist; CD: Chagas disease; EC: Endothelial cells; INR: International normalized ratio; LV: Left ventricle; PT: Prothrombin time; SMC: Smooth muscle cell; TF: Tissue factor; Tc: Trypanosoma cruzi; uPA: Urokinase plasminogen activator; VCAM1: Vascular Cell adhesion molecule 1; VEGF: Vascular endothelial growth factor.
No takes yet. Share an insight, caveat, or question.
Choudhuri et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: